The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Trunin Yu.Yu.

Burdenko Neurosurgical Center

Golanov A.V.

Burdenko Neurosurgical Center

Konovalov A.N.

Burdenko Neurosurgical Center

Pronin I.N.

Burdenko Neurosurgical Center

Pseudoprogression of intracranial pilocytic astrocytomas and other low-grade gliomas. Literature review and case report

Authors:

Trunin Yu.Yu., Golanov A.V., Konovalov A.N., Pronin I.N.

More about the authors

Journal: Burdenko's Journal of Neurosurgery. 2020;84(6): 105‑111

Read: 4035 times


To cite this article:

Trunin YuYu, Golanov AV, Konovalov AN, Pronin IN. Pseudoprogression of intracranial pilocytic astrocytomas and other low-grade gliomas. Literature review and case report. Burdenko's Journal of Neurosurgery. 2020;84(6):105‑111. (In Russ., In Engl.)
https://doi.org/10.17116/neiro202084061105

References:

  1. Macdonald DR, Cascino TL, Schold SC, Cairncross JG. Response criteria for phase II studies of supratentorial malignant glioma. Journal of Clinical Oncology. 1990;8(7):1277-1280. https://doi.org/10.1200/JCO.1990.8.7.1277
  2. Chang SM, Wen PY, Vogelbaum MA, Macdonald DR, van den Bent MJ. Response Assessment in Neuro-Oncology (RANO): more than imaging criteria for malignant glioma. Neuro-Oncology Practice. 2015;2(4):205-209.  https://doi.org/10.1093/nop/npv037
  3. van den Bent MJ, Wefel JS, Schiff D, Taphoorn MJB, Jaeckle K, Junck L, Armstrong T, Choucair A, Waldman AD, Gorlia T, Chamberlain M, Baumert BG, Vogelbaum MA, Macdonald, Reardon DA, Wen PY, Chang SM, Jacobs AH. Response assessment in neuro-oncology (a report of the RANO group): assessment of outcome in trials of diffuse low-grade gliomas. The Lancet. Oncology. 2011;12(6):583-593.  https://doi.org/10.1016/S1470-2045(11)70057-2
  4. Warren KE, Poussaint TY, Vezina G, Hargrave D, Packer RJ, Goldman S, Wen PY, Pollack IF, Zurakowski D, Kun LE, Prados MD, Rutkowski S, Kieran MW. Challenges with defining response to antitumor agents in pediatric neuro-oncology: a report from the response assessment in pediatric neuro-oncology (RAPNO) working group. Pediatric Blood and Cancer. 2013;60(9):1397-1401. https://doi.org/10.1002/pbc.24562
  5. Gaudino S, Martucci M, Russo R, Visconti E, Gangemi E, D’Argento F, Verdolotti T, Lauriola L, Colosimo C. MR imaging of brain pilocytic astrocytoma: beyond the stereotype of benign astrocytoma. Child’s Nervous System: ChNS. 2017;33(1):35-54.  https://doi.org/10.1007/s00381-016-3262-4
  6. Kruser TJ, Mehta MP, Robins HI. Pseudoprogression after glioma therapy: a comprehensive review. Expert Review of Neurotherapeutics. 2013;13(4):389-403.  https://doi.org/10.1586/ern.13.7
  7. Foster KA, Ares WJ, Pollack IF, Jakacki RI. Bevacizumab for symptomatic radiation-induced tumor enlargement in pediatric low grade gliomas. Pediatric Blood and Cancer. 2015;62(2):240-245.  https://doi.org/10.1002/pbc.25277.
  8. Trunin YY, Golanov AV, Konovalov AN, Shishkina LV, Gorlachev GE, Gorelyshev SK, Pronin IN, Khukhlayeva EA, Serova NK, Korshunov AG, Melikian AG, Ryzhova MV, Kadyrov SU, Sorokin VS, Mazerkina NA, Mariashev SA, Il’ialov SR, Kostiuchenko VV. Stereotactic radiotherapy and radiosurgery in treatment of patients with deep-seated pilocytic astrocytomas. Voprosy neirokhirurgii im. N.N. Burdenko. 2012;76(1):64-78. (In Russ.).
  9. Trunin YY, Golanov AV, Konovalov AN, Shishkina LV, Gorlachev GE, Pronin IN, 11th International Stereotactic Radiosurgery Society Congress (ISRS 2013). Journal of Radiosurgery and SBRT. 2013;2(suppl 1):1-177. Accessed June 20, 2020. https://pubmed.ncbi.nlm.nih.gov/29296377
  10. Trunin YY, Golanov AV, Kostyuchenko VV, Galkin MV, Khukhlaeva EA, Konovalov AN. Enlarged piloid astrocytoma of the midbrain: recurrence or pseudoprogression? A clinical case. Opuholi golovy i shei. 2016;6(1):68-70. (In Russ.). https://doi.org/10.17650/2222-1468-2016-6-1-68-70
  11. Trunin Y, Golanov AV, Kostjuchenko VV, Galkin M, Konovalov AN. Pilocytic Astrocytoma Enlargement Following Irradiation: Relapse or Pseudoprogression? Cureus. 2017;9(2):e1045. https://doi.org/10.7759/cureus.1045
  12. Trunin YY, Golanov AV, Konovalov AN, Shishkina LV, Gorlachev GE, Gorelyshev SK, Pronin IN, Khukhlayeva EA, Serova NK, Korshunov AG, Bekyashev AK, Ryzhova MV, Galkin MV, Kadyrov SU, Sorokin VS, Mazerkina NA, Maryashev SA, Vetlova ER, Antipina NA, Kostyuchenko VV, Pankova AS. Stereotactic radiotherapy and radiosurgery in the treatment of patients with brain piloid astrocytomas of deep location. Opuholi golovy i shei. 2012;3:17-26. (In Russ.). https://doi.org/10.17650/2222-1468-2012-0-3-17-26
  13. Trunin YY, Golanov AV, Shishkina LV, Ryzhova MV, Pronin IN, Fomichev DV, Trunina EN, Shneiderman MG. Sposob diagnostiki recidivnyh sostoyanij piloidnyh astrocitov golovnogo mozga posle provedennoj luchevoj terapii i lechenie pri vyyavlenii recidivov ili inyh sostoyanij. Patent RF na izobretenie RU 2 681 299 C2/2019.03.05. Accessed September 09, 2020. (In Russ.). https://patents.s3.yandex.net/RU2017124352A_20190111.pdf
  14. Constine LS, Konski A, Ekholm S, McDonald S, Rubin P. Adverse effects of brain irradiation correlated with MR and CT imaging. International Journal of Radiation Oncology, Biology, Physics. 1988;15(2):319-330.  https://doi.org/10.1016/S0360-3016(98)90011-6
  15. Packer RJ, Zimmerman RA, Kaplan A, Wara WM, Rorke LB, Selch M, Goldwein J, Allen JA, Boyett J, Albright AL, Finlay JL, Hammond GD. Early cystic/necrotic changes after hyperfractionated radiation therapy in children with brain stem gliomas data from the childrens cancer group. Cancer. 1993;71(8):2666-2674. https://doi.org/10.1002/1097-0142(19930415)71:8<2666:AID-CNCR2820710836>3.0.CO,2-K "> 3.0.CO,2-K" target="_blank">https://doi.org/10.1002/1097-0142(19930415)71:8<2666:AID-CNCR2820710836>3.0.CO,2-K
  16. Poussaint TY, Siffert J, Barnes PD, Pomeroy SL, Goumnerova LC, Anthony DC, Sallan SE, Tarbell NJ. Hemorrhagic vasculopathy after treatment of central nervous system neoplasia in childhood: diagnosis and follow-up. American Journal of Neuroradiology. 1995;16(4):693-699. Accessed September 09, 2020. https://www.ajnr.org/content/16/4/693
  17. Pozza F, Colombo F, Chierego G, Avanzo RC, Marchetti C, Benedetti A, Casentini L, Danieli D. Low-grade astrocytomas: treatment with unconventionally fractionated external beam stereotactic radiation therapy. Radiology. 1989;171(2):565-569.  https://doi.org/10.1148/radiology.171.2.2495561
  18. Bakardjiev AI, Barnes PD, Goumnerova LC, Black PM, Scott RM, Pomeroy SL, Billett A, Loeffler JS, Tarbell NJ. Magnetic resonance imaging changes after stereotactic radiation therapy for childhood low grade astrocytoma. Cancer. 1996;78(4):864-873. https://doi.org/10.1002/(SICI)1097-0142(19960815)78:4<864:AID-CNCR25>3.0.CO,2-S "> 3.0.CO,2-S" target="_blank">https://doi.org/10.1002/(SICI)1097-0142(19960815)78:4<864:AID-CNCR25>3.0.CO,2-S
  19. Mansur DB, Rubin JB, Kidd EA, King AA, Hollander AS, Smyth MD, Limbrick DD, Park TS, Leonard JR. Radiation therapy for pilocytic astrocytomas of childhood. International Journal of Radiation Oncology, Biology, Physics. 2011;79(3):829-834.  https://doi.org/10.1016/j.ijrobp.2009.11.015
  20. Naftel RP, Pollack IF, Zuccoli G, Deutsch M, Jakacki RI. Pseudoprogression of low-grade gliomas after radiotherapy. Pediatric Blood and Cancer. 2015;62(1):35-39.  https://doi.org/10.1002/pbc.25179
  21. Tsang DS, Murphy ES, Lucas JT, Lagiou P, Acharya S, Merchant TE. Pseudoprogression in pediatric low-grade glioma after irradiation. Journal of Neuro-Oncology. 2017;135(2):371-379.  https://doi.org/10.1007/s11060-017-2583-9
  22. Mannina EM, Bartlett GK, McMullen KP. Extended Volumetric Follow-up of Juvenile Pilocytic Astrocytomas Treated with Proton Beam Therapy. International Journal of Particle Therapy. 2016;3(2):291-299.  https://doi.org/10.14338/IJPT-16-00020.1
  23. Ludmir EB, Mahajan A, Paulino AC, Jones JY, Ketonen LM, Su JM, Grosshans DR, McAleer MF, McGovern SL, Lassen-Ramshad YA, Adesina AM, Dauser RC, Weinberg JS, Chintagumpala MM. Increased risk of pseudoprogression among pediatric low-grade glioma patients treated with proton versus photon radiotherapy. Neuro-Oncology. 2019;21(5):686-695.  https://doi.org/10.1093/neuonc/noz042
  24. Indelicato DJ, Rotondo RL, Uezono H, Sandler ES, Aldana PR, Ranalli NJ, Beier AD, Morris CG, Bradley JA. Outcomes Following Proton Therapy for Pediatric Low-Grade Glioma. International Journal of Radiation Oncology, Biology, Physics. 2019;104(1):149-156.  https://doi.org/10.1016/j.ijrobp.2019.01.078
  25. Chawla S, Korones DN, Milano MT, Hussain A, Hussien AR, Muhs AG, Mangla M, Silberstein H, Ekholm S, Constine LS. Spurious progression in pediatric brain tumors. Journal of Neuro-Oncology. 2012;107(3):651-657.  https://doi.org/10.1007/s11060-011-0794-z
  26. Omuro A, DeAngelis LM. Glioblastoma and other malignant gliomas: a cli-nical review. JAMA. 2013;310(17):1842-1850. https://doi.org/10.1001/jama.2013.280319
  27. Brandes AA, Franceschi E, Tosoni A, Blatt V, Pession A, Tallini G, Bertorelle R, Bartolini S, Calbucci F, Andreoli A, Frezza G, Leonardi M, Spagnolli F, Ermani M. MGMT promoter methylation status can predict the incidence and outcome of pseudoprogression after concomitant radiochemotherapy in newly diagnosed glioblastoma patients. Journal of Clinical Oncology. 2008;26(13):2192-2197. https://doi.org/10.1200/JCO.2007.14.8163

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.